Category Archives: Stage Four Cancer Treatment

Olivia Newton John Shares News of Her Breast Cancer Metastasis

Olivia Newton John Shares News of Her Breast Cancer Metastasis
Olivia Newton John Shares News of Her Breast Cancer Metastasis

Actress and singer Olivia Newton-John has campaigned to raise awareness of cancer research since she began fighting the disease in 1992. In May she made the sad announcement that her breast cancer had returned and spread to her lower spine.

The Prognosis for Metastatic Breast Cancer

Newton-John’s breast cancer is metastatic, also known as Stage IV, which refers to cancer that begins in one area of the body and spreads to other organs or tissues. It was discovered when the singer postponed a concert tour due to lower back pain that was originally thought to be sciatica.

Family and friends remain positive, and Newton-John herself plans to resume touring in August. While metastatic breast cancer is a serious issue, doctors say that Newton-John and other women with this diagnosis have reason for optimism.

Five-Year Survival by the Numbers

A recent study published in Cancer Epidemiology, Biomarkers & Prevention discovered that the five-year survival rate for women with metastatic breast cancer had reached 36 percent during the last 10 years. That number is double the five-year survival rate for women diagnosed in the early 1990s.

According to Dr. Sagar Sardesai of the Ohio State University Comprehensive Cancer Center, the healthcare community has begun thinking of metastatic breast cancer as a chronic disease. Physicians are working with patients cancer treatment programs that relieve symptoms and improve their quality of life.

Stage IV Cancer Treatment at Issels®

If you have been diagnosed with metastatic cancer, there is hope. Visit our website to read and hear testimonials from patients with Stage IV cancer in all forms who have been successfully treated with our immunotherapy programs.

NIH Calls Proposed Cancer Research Funding Cuts Unacceptable

NIH Calls Proposed Cancer Research Funding Cuts Unacceptable
NIH Calls Proposed Cancer Research Funding Cuts Unacceptable

Can you put a price on good health? Major medical organizations have been reacting strongly to proposed deep cuts in scientific and medical research funding that would severely hamper research programs such as immunotherapy for cancer.

Drastic Slashes in Scientific Research Funding and Healthcare Coverage

Stipulations in the Trump administration’s proposed 2018 budget that are drawing the biggest backlash include:

• The National Institutes of Health (NIH) would see a staggering $5.8 billion reduction in overall funding, of which $1 billion would come out of the budget for the National Cancer Institute (NCI).

• Over the next 10 years Medicaid funding would be reduced by $600 billion, resulting in lack of health insurance for needy groups such as children, elderly and disabled.

The Scientific and Medical Community Responds

Daniel F. Hayes, M.D., president of the American Society of Clinical Oncology (ASCO), explained that many major breakthroughs in cancer research have come from federally-funded organizations such as the NIH. In addition, federal research funding allows the scientific and medical industry to generate $60 billion a year in economic activity.

Similar concern was expressed by Chris Hansen, president of the American Cancer Society’s Cancer Action Network (ACS CAN). He referred to polls showing that 90 percent of voters rate federal funding for medical research as “very” or “extremely” important, with 75 percent supporting an increase in NIH funding.

Building on the Issels® Legacy

Our immunotherapy for cancer clinic has carried on the high standards and innovative programs of our founder, Josef M. Issels. Contact us to learn more about our personally tailored, state-of-the-art treatments such as cancer vaccines and NK cells.

Our Patient Testimonials Give an Insiders’ View of Our Cancer Treatments

Get The Treatment You Need with Us!
Get The Treatment You Need with Us!

When it comes to cancer treatment at Issels®, no one can speak about it more eloquently than our patients. Here’s what they have to say in their testimonials about our integrative immunotherapy programs.

In Our Patients’ Own Words: The Issels® Difference

  • Gerhard Uhlemann was diagnosed with an epipharynx tumor of the head and neck. As he explains, “I was 12 years old and I am still thankful that Dr. Issels saved my life. Back then the University Clinic gave me two weeks to live.” After treatment, Uhlemann remained cancer-free for more than 30 years.
  • At the age of six, Emma Banks was diagnosed with a Wilms tumor. Two years after a nephrectomy of her left kidney, Emma experienced a relapse with two tumors in her left lung. Emma’s mother Susan relates that, thanks to treatment at Issels®, her daughter “has been in remission for almost nine years now without any standard treatment.”
  • When Kenneth Scoones lost his lymph nodes to melanoma, he was told the cancer had metastasized to his lungs and his life expectancy was one year at most. After four weeks at Issels®, a CT scan revealed that the metastases had disappeared. Scoones states that from his arrival, “The doctors, nurses, all the staff responded, showed care and affection, and compassion – everything that was needed for a patient with this sort of disease.”

Immunotherapy: Going Beyond Standard Cancer Treatment

Our innovative immunotherapy methods boost the natural power of your body’s own immune system. Contact us to learn more about cancer vaccines, NK cells and other non-toxic cancer treatments at Issels®.

PBS News Hour Features Immunotherapy for Cancer

Diverse Hands Holding The Word Cancer
Immunotherapy brings breakthroughs to cancer treatment.

As immunotherapy for cancer becomes an increasingly valuable method for fighting tumors, stories have moved from medical journals into the mainstream media. Immunotherapy was the topic of a recent edition of Leading Edge, a weekly science and technology report featured on PBS News Hour.

Immunotherapy: One Woman’s Story

First up were Melinda Welsh, a journalist who was diagnosed with squamous cell carcinoma, and her oncologist, Dr. Alain Algazi of the University of California, San Francisco. When Melinda’s cancer metastasized, her doctors told her she had no more than a year to live.

Dr. Algazi began treating Melinda with an immunotherapy method known as a checkpoint inhibitor, which releases the “brakes” that prevent the body’s immune system from attacking tumor cells. Melinda then went into remission and continues today, three years after receiving her original diagnosis.

The Immunotherapy Difference

Host Hari Sreenivasan then conducted a discussion with Dr. Jeffery Bluestone, CEO of Parker Institute for Cancer Immunotherapy, and New York Times reporter Matt Richter.

Highlights of the conversation include:

Immunotherapy for cancer differs drastically from other treatments in that it uses the body’s natural power rather than poisons to fight tumors.

• Richter, who has profiled a number of cancer patients, characterized immunotherapy as a “quantum leap” in the fight against cancer.

• Dr. Bluestone cited the example of melanoma, which has gone from 5 percent five-year survival to 40 percent five-year survival.

A Personalized Approach

Our non-toxic immunotherapy for cancer treatments are tailored to meet your specific needs. Visit our website to read and hear success stories from patients who have been treated at our Issels® clinics.

The Unquestionable Game Changer in Cancer Treatment

Integrative Immunotherapy is the Unquestionable Game Changer in Cancer Treatment
Integrative Immunotherapy is the Unquestionable Game Changer in Cancer Treatment

As recently as 15 years ago, the chances of survival for a patient whose melanoma had spread to other parts of the body were only slightly more than zero. Today, thanks to advancements in the area of integrative immunotherapy, these patients have a legitimate source of hope.

Paving the way for treatment

Pete Daly was one of those patients for whom a diagnosis of metastatic melanoma meant a bleak future. With immunotherapy entering a clinical trial phase, Daly believed his participation would give meaning to his situation by helping others.

Up to that point, testing had been done only on monkeys. It didn’t take long to see results as within weeks Daly’s doctors found that his tumors were shrinking. Currently, 13 years after testing Daly continues to show no signs of cancer.

Former President Jimmy Carter is another patient who has benefited from integrative immunotherapy. He is also no longer showing signs of the melanoma that had formed in his liver and brain.

Immunotherapy is a “game changer”

Oncologist Dr. Mark Albertini of the Carbone Cancer Center at University of Wisconsin Health credits the courage of patients like Daly for contributing to the development of immunotherapy treatments, which he refers to as “game changers.” Dr. Albertini stresses that early detection is still key to successful cancer treatment.

Issels® has been a pioneer in the use of integrative immunotherapy treatments that are personalized to meet each patient’s individual needs. Visit our website today to learn more about our cancer vaccines and other advanced non-toxic cancer treatment protocols.

What to Understand about Metastatic Cancer

Understanding Stage IV
Understanding Stage IV

Have you heard reference to the term “metastatic cancer” but you’re unsure what it means? It may sound like a technical term, but it’s a relatively straightforward concept. Here are some facts to help demystify the issue.

Metastatic cancer is also called “stage IV” or “advanced”

All three terms refer to cancer that has spread from its original location to other parts of the body. Metastasis is the process by which cancer cells migrate via the blood or lymph system.

Metastatic tumors are treated the same as the original tumors

The tumors are called by the same name and treated with the same protocols as the primary cancer. If the original location cannot be determined, it’s considered to be carcinoma of unknown primary origin, or CUP. The patient undergoes a series of diagnostic tests to help doctors zero in on possible locations of the main tumor as well as appropriate courses of treatment.

Different forms of cancer are more likely to travel to particular areas

For example, breast cancer most commonly metastasizes to the lungs or bones. In addition, stage IV cancer may spread to one or several additional locations.

Metastatic cancer can be successfully treated

While the spread of tumors is a serious development, medical advances have made significant improvements in life expectancy for stage IV patients. Ongoing tests and studies continue to make breakthroughs in effective protocols.

Our state-of-the-art, non-toxic immunotherapy protocols boost your body’s own ability to fight cancer at any stage. Contact us to learn more about our comprehensive, individualized treatment programs at Issels®.